NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanochon

Nanochon

Private
Washington D.C.Healthcare & Life Scienceshttps://nanochon.com/

Last Round

Seed

Jan 12, 2026

Est. Valuation

$4M

Total Funding Raised

$10.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nanochon is a medical device company developing 3D-printed, synthetic implants designed to repair cartilage and encourage new tissue growth for patients with joint injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantcartilage repairtissue engineering3D-printed implantregenerative medicineorthopedic scaffoldosteoarthritis treatmentbiotech implantmedical devicejoint repairmedtechhyaline cartilageorthobiologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanochon Comparables

Compare Nanochon with similar companies based on industry and business-model similarity.

Nanochon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Regentis Biomaterials Ltd.
84%
Sparta Biomedical
83%
Askel Healthcare
83%

Nanochon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 12, 2026
GrantOct 2, 2025
SeedMay 6, 2024
SeedOct 21, 2021
GrantJul 1, 2017

Key People

Founding team and executive leadership

Nathan Castro

Co-Founder And CTO

Founding Team

Benjamin Holmes

Member Board Of Directors, Chief Executive Officer

Executive Team

Matthew Scherer

Chief Financial Officer

Executive Team

Nanochon Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 152% MoM.

  • Oct 2, 2025

    Received grant from Maryland Stem Cell Research Fund.

Nanochon Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanochon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanochon's valuation, stock price, and market status.

Firmographic Details

HeadquartersWashington D.C.
Employee Range15
Year Founded2013
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.